Ryan Mee, CEO of Fulcrum Metals, reviews FY23 and progress on the Gold Tailings Hub in Canada. Watch the video here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Drop in share price. Are results not good
Morning. I wonder if this has anything to do with the recent share price excitement here. 742, 000 more scans! https://www.thenorthernecho.co.uk/news/national/23700371.government-turns-private-clinics-help-tackle-nhs-waiting-lists/
Financial highlights:
· The Group expects to report that revenue for the period to 30 June 2023 has grown by 3% to £6.1m (H1 2022: £5.9m)
o H1 2022 revenue figures included £1.4m of one-off orders from the NHS in the UK, so on an adjusted like-for-like basis, revenue in H1 2023 is expected to have increased by 35% (H1 2022 adjusted: £4.5m)
· The Group's clinical AI products continue to gain traction and revenues are expected to have more than doubled to £0.7m (H1 2022: £0.3m)
· Cash at bank on 30 June 2023 was £3.4m (31 December 2022: £7.2m), impacted by working capital seasonality in H1
· Cash utilisation in H2 is expected to be materially lower and the Group remains on target to reach profitability with its current cash
24th July RNS Trading Update.
Really positive news. Confirmation will reach profitability with current cash.
Onwards and upwards!
V v quite overall. With a key guy retiring not sure what to make of this. Certainly looks good on paper hence my investment
Whats woke this up??
Another 12.86% price rise
Walked in to the door.
.....but at 6.9%, the spread is waaaay you wide:-(
New investor this morning. Bought in using KOD profit and looking for a little peace here.
Steady gains here. All looking good.
:-)
So far today about 2k sold and about 95k BROUGHT! Shares up just over 12%.
AI & healthcare
LONDON, April 24 (Reuters) - Britain on Monday announced 100 million pounds ($124.5 million) in initial funding for a taskforce to help develop foundation models - a type of artificial intelligence used by chatbots like ChatGPT - for use in fields like healthcare and education.
"Harnessing the potential of AI provides enormous opportunities to grow our economy, create better-paid jobs, and build a better future through advances in healthcare and security," British Prime Minister Rishi Sunak said.
"By investing in emerging technologies through our new expert taskforce, we can continue to lead the way in developing safe and trustworthy AI as part of shaping a more innovative UK economy."
Sold about 3k , brought about 58k looks like a lot of investors like this company. I won’t be adding any more shares just yet,
Going strong again today, with a lot of buys coming in. I have made a little purchase myself this morning. I'm convinced there is a II buying in and hopefully some good new on the way as well (just speculating).
today
So normally no trades or minimal trades here have caused low SP over time.
Final results out Thursday and revenue has grown tear to year. It normally has a yearly spike on momentum and then settles again.
However the AI programs and training modules are sold to medical establishments around the world and the SP always seems too low for what the company produces. Scan AI aid for operations and training simulation dummies along with licensing. So should become clearer this week what this year has bought
bounce up was due and midas helped ...HELD ...worth a look too imho
There is a huge amount of trades going through....and they do look like a lot of round numbers. Maybe an II?
Don't know the full history here yet but it seems to me like the trading today is massive against normal days. And I cant think that the Midas recommendation will the the only reason for that .
I can't believe that this share price has increased today by such a ridiculous amount on the back of a midas recommendation and no actual RNS
Small medical shares like this have a habit of either going bust or requiring lots of money
Also, MIDAS don't exactly have a good track record
May be a great company but best wait until the hype has died down
this definitely has the midas touch today
wow up 68 percent now
12P TAKEN OUT
THIS IS MOVING UP NICELY SO IS MY OTHER ONE TODAY EDEN
THIS SEEMS TO BE READY FOR LIFT OFF GIVEN EARLY MORNING TRADES
Interesting share. Looking at the news around looks like they are growing at a good pace. Definitely doing a bit more research here, with the idea of buying....